Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Celgene Corporation (CELG)

-NasdaqGS
131.25 Down 0.63(0.48%) Jul 31, 4:00PM EDT
|After Hours : 131.65 Up 0.40 (0.30%) Jul 31, 5:48PM EDT
Add to Portfolio
Prev Close:131.88
Open:132.83
Bid:130.92 x 100
Ask:131.95 x 300
1y Target Est:152.89
Beta:2.04
Earnings Date:Oct 21 - Oct 26 (Est.)
Day's Range:130.77 - 133.00
52wk Range:83.16 - 140.72
Volume:3,546,702
Avg Vol (3m):4,658,460
Market Cap:104.10B
P/E (ttm):49.70
EPS (ttm):2.64
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 0.48%104.10B
JNJUp 0.37%277.89B

Key Statistics

Forward P/E (1 yr):21.91
P/S (ttm):12.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :4.80
Quarterly EPS Est (Sep-15) :1.22
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback